Oncology One is focused on building a diversified small molecule oncology pipeline and aims to help translate more of Australia’s world-class cancer research into treatments.
Oncology One has a purpose-built business model to deliver targeted investment to research teams and works with them to progress important research towards the clinic.
We are working to curate and develop high quality programs that aim to meet yet unmet clinical needs in oncology, inclusive of underserved areas such as paediatric and rare cancers.
To learn more about investment or partnership opportunities with Oncology One, visit oncologyone.com.au
Company Details
- Employees
- 2
- Founded
- 2007
- Address
- 305 Grattan Street, Melbourne,vic 3000,australia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://oncologyone.com.au/
- HQ
- Melbourne, VIC
Oncology One Pty Ltd Questions
Oncology One Pty Ltd's website is https://oncologyone.com.au/
Oncology One Pty Ltd's LinkedIn profile is https://au.linkedin.com/company/oncologyone
Oncology One Pty Ltd has
2 employees.
View email and phone details for 2
employees at Oncology One Pty Ltd.
Oncology One Pty Ltd's industry is
Biotechnology Research
Oncology One Pty Ltd's top competitors are
Anaxis Pharma,
Imugene Limited,
Ternarx,
Canthera Discovery (Canthera Discovery Ltd),
Gertrude Biomedical,
Aculeus Therapeutics,
Rhythm Biosciences Limited,
Oneoncology,
Genetype,
Amplia Therapeutics Limited.
Oncology One Pty Ltd's categories are Biotechnology Research
Oncology One Pty Ltd's founding year is 2007
